- Home
- OVLY vs RCKT Comparison
OVLY vs RCKT Comparison
Compare OVLY & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OVLY | RCKT |
|---|---|---|
| Founded | 1990 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.1M | 277.7M |
| IPO Year | 2008 | 2014 |
Fundamental Metrics
Financial Performance| Metric | OVLY | RCKT |
|---|---|---|
| Price | $34.50 | $2.32 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $8.58 |
| AVG Volume (30 Days) | 9.2K | ★ 1.6M |
| Earning Date | 10-21-2026 | 11-12-2026 |
| Dividend Yield | ★ 4.34% | N/A |
| EPS Growth | N/A | ★ 26.37 |
| EPS | ★ 2.02 | 0.23 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1,102.46 |
| P/E Ratio | $17.03 | ★ $3.64 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $27.21 | $2.17 |
| 52 Week High | $36.08 | $5.45 |
Technical Indicators
Market Signals| Indicator | OVLY | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 52.55 | 41.72 |
| Support Level | $32.82 | $2.23 |
| Resistance Level | $35.75 | $2.73 |
| Average True Range (ATR) | 0.82 | 0.19 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 43.12 | 24.84 |
Price Performance
Historical ComparisonAbout OVLY Oak Valley Bancorp (CA)
Oak Valley Bancorp is a bank holding company that operates through Oak Valley Community Bank (the Bank). The Bank offers a complement of business checking and savings accounts for its business customers. The Bank also offers commercial and real estate loans, as well as lines of credit. In addition, the bank provides other services for both individuals and businesses including online banking, remote deposit capture, mobile banking, merchant services, night depository, extended hours, wire transfer of funds, note collection, and automated teller machines in a national network. Its primary source of revenue is net interest income.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.